The World Health Organization has approved the first medicine specifically designed to treat malaria in infants.
The drug, known as Coartem Baby, has been developed to address the needs of very young children affected by the disease. Health experts say this marks an important step in improving treatment options for infants, who are among the most vulnerable to malaria.
Malaria continues to be a major health concern in many parts of the world, especially in regions with limited access to healthcare. Treating infants has been a challenge due to the lack of medicines tailored for their age and weight.
The approval of Coartem Baby is expected to support safer and more effective treatment for young patients. It may also help reduce complications linked to severe malaria in early childhood.
Officials noted that the medicine will play a role in strengthening efforts to control and manage malaria globally.
The development highlights progress in providing targeted healthcare solutions for vulnerable groups.
0 Comments